Clinical Trials Browser

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Clinical Trials

STARTRK-2

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

PTC-RFA

Clinical Utility of Preoperative Thyroid GuidePx® Testing

Studies on Tumors of the Thyroid

IoN

Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

PRO-COMAND

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

Decision Aid Efficacy in Low Risk Thyroid Cancer

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

LIBRETTO-001

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

STRAP

STARTRK-NG

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

DUTHY

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

DETERMINE

Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma

MAPS

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

IDENTHY-K

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound

MHI

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

LIBRETTO-121

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

AS-PTC

DETERMINE

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

cN0PTC

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

TEMPEST

Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma